Department of Cardiology, Children's Hospital Boston, Boston, MA 02115, USA.
Circ Heart Fail. 2012 Mar 1;5(2):249-58. doi: 10.1161/CIRCHEARTFAILURE.111.964247. Epub 2012 Jan 13.
A change in allocation algorithm in July 2006 allowed broader regional sharing of donor hearts in the United States (US). We assessed if the allocation change has been associated with a decline in wait list mortality in the US.
We compared baseline characteristics and outcomes in patients ≥18 years old listed for a primary heart transplant in the US before (July 1, 2004-July 11, 2006, Era1) and after (July 12, 2006-June 30, 2009, Era 2) the change in allocation algorithm. Of 11 864 patients in the study, 4503 were listed during Era 1 and 7361 during Era 2. Patients listed during Era 2 were more likely to be listed status 1A, have an implantable cardioverter-defibrillator, and supported on a continuous flow assist device (P<0.001 for distribution. Patients listed in Era 2 were at a 17% lower risk of dying on the wait list or becoming too sick to transplant (adjusted hazard ratio, 0.83, 95% CI 0.75, 0.93). Transplant recipients in Era 2 were more likely to be transplanted as status 1A (37% versus 48%, respectively, P<0.001). Post-transplant in-hospital mortality (6.3% versus 5.4%; adjusted odds ratio, 0.86 for Era 2, 95% CI 0.79, 1.06) and 1-year survival were similar.
The risk of death on the wait list or becoming too sick to transplant has decreased by 17% in the US since the allocation algorithm allowing broader regional sharing was implemented in 2006. The shift in hearts to sicker candidates has not resulted in higher in-hospital or first year post-transplant mortality.
2006 年 7 月,美国(美国)改变了分配算法,允许更广泛的地区共享供体心脏。我们评估了分配变化是否与美国候补名单死亡率的下降有关。
我们比较了美国年龄在 18 岁以上的患者在分配算法改变前后(2004 年 7 月 1 日至 2006 年 7 月 11 日,Era1;2006 年 7 月 12 日至 2009 年 6 月 30 日,Era2)的基线特征和结果。在研究中,有 11864 名患者,4503 名患者在 Era1 期间登记,7361 名患者在 Era2 期间登记。Era2 期间登记的患者更有可能被列为 1A 状态,植入式心律转复除颤器,以及连续流动辅助设备支持(P<0.001)。Era2 期间登记的患者在候补名单上死亡或病情恶化到无法移植的风险降低了 17%(调整后的危险比,0.83,95%CI 0.75,0.93)。Era2 中的移植受者更有可能作为 1A 状态接受移植(分别为 37%和 48%,P<0.001)。移植后住院死亡率(6.3%对 5.4%;Era2 的调整优势比,0.86,95%CI 0.79,1.06)和 1 年生存率相似。
自 2006 年实施允许更广泛地区共享的分配算法以来,美国候补名单上的死亡风险或病情恶化到无法移植的风险降低了 17%。向病情较重的候选者转移心脏并没有导致住院或移植后 1 年死亡率更高。